CABANA trial: “beauty is in the eye of the beholder”

David Briceno, Prasant Mohanty, Luigi Di Biase, Jorge Romero, Domenico Giovanni Della Rocca, Chintan Trivedi, Sanghamitra Mohanty, Andrea Natale

Research output: Contribution to journalComment/debate

Abstract

The CABANA trial reported that catheter ablation, when compared with drug therapy, did not significantly reduce the primary composite end point of death, disabling stroke, serious bleeding, or cardiac arrest in patients with atrial fibrillation. Despite multiple limitations in study design, the CABANA trial still confirmed that catheter ablation of atrial fibrillation led to clinically important and significant improvements in quality of life at 12 months without increasing the risk of complications.

Original languageEnglish (US)
JournalJournal of Interventional Cardiac Electrophysiology
Volume57
Issue number1
DOIs
StatePublished - Jan 1 2020

    Fingerprint

Keywords

  • Ablation
  • Atrila fibrillation
  • Mortality
  • Outcomes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this